Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

Serum Institute says AstraZeneca’s COVID-19 vaccine safe, no co-relation with side-effects

PTI
Updated: December 1st, 2020, 16:54 IST
in Coronavirus, Home News, National
0
Vaccine

Photo courtesy: tribuneindia.com

Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

New Delhi: Serum Institute of India (SII), the world’s largest vaccine manufacturer, denied allegations Tuesday that a COVID-19 trial volunteer suffered serious side effects from a vaccine developed by AstraZeneca and Oxford University. Serum Institute said that the vaccine is safe and immunogenic. “We would want to assure everyone that the vaccine won’t be released for mass use. Unless it is proven immunogenic, and safe, it will not be available for public,” SII said in a blog.

Last week, a volunteer in Chennai claimed to have suffered serious neurological and psychological symptoms after taking the experimental shot. He has sued the company along with others and a sought compensation of Rs 5 crore.

Also Read

Supreme Court

SC restrains trial court from taking up chargesheet against Ashoka University professor

1 hour ago
Samay Raina

SC directs social media influencers to display apology for mocking disabled persons

1 hour ago

“The incident with the Chennai volunteer, though highly unfortunate was in no way induced by the vaccine. Serum Institute of India is sympathetic with the volunteer’s medical condition,” the Pune-based institute said.

Serum is conducting trials of AstraZeneca’s vaccine in India as part of a manufacturing agreement. “Taking into consideration the complexities and existing misnomers about vaccination and immunisation; the legal notice was sent (to the volunteer) therefore to safeguard the reputation of the company which is being unfairly maligned,” SII informed.

Also read: AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum Institute

It said all the requisite regulatory and ethical processes and guidelines were followed diligently and strictly.

“The concerned authorities were informed. The principal investigator, DSMB and the Ethics Committee independently cleared and reckoned it as a non-related issue to the vaccine trial,” the vaccine manufacturing company said.

“Post which, we submitted all the reports and data related to the incident to the DCGI (Drugs Controller General of India). It is only after we cleared all the required processes that we continued with the trials,” SII added.

In response to claims made by the volunteer, Serum had Sunday stated that the allegations were ‘malicious and misconceived’.

 

Tags: AstraZenecaDCGIOxford UniversitySerum Institutevaccinevolunteer
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Mrutyunjaya Behera

December 12, 2019
#MyPaperBagChallenge

Jyotshna Mayee Pattnaik

December 12, 2019
#MyPaperBagChallenge

Parbati Mohanty

December 12, 2019
#MyPaperBagChallenge

Smitarani Sahoo

December 12, 2019
#MyPaperBagChallenge

Archit Mohapatra

December 12, 2019
#MyPaperBagChallenge

Pratik Kumar

December 12, 2019
#MyPaperBagChallenge

Narendra Kumar

December 12, 2019
#MyPaperBagChallenge

D Rama Rao

December 12, 2019
#MyPaperBagChallenge

Akriti Negi

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Sipra Mishra

December 12, 2019
#MyPaperBagChallenge

Anasuya Sahoo

December 12, 2019
#MyPaperBagChallenge

Faiza Firdous

December 12, 2019
#MyPaperBagChallenge

Pitabas Tripathy

December 12, 2019
#MyPaperBagChallenge

Sitakanta Mohanty

December 12, 2019
#MyPaperBagChallenge

Geetanjali Patro

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
#MyPaperBagChallenge

Dibya Ranjan Das

December 12, 2019
#MyPaperBagChallenge

Adyasha Priyadarsani Sendha

December 12, 2019
#MyPaperBagChallenge

Tabish Maaz

December 12, 2019
#MyPaperBagChallenge

Shreyanshu Bal

December 12, 2019
#MyPaperBagChallenge

Pratyasharani Ghibela

December 12, 2019
#MyPaperBagChallenge

Jhili Jena

December 12, 2019
#MyPaperBagChallenge

Surya Sidhant Rath

December 12, 2019
#MyPaperBagChallenge

Spinoj Pattnaik

December 12, 2019
#MyPaperBagChallenge

Akshaya Kumar Dash

December 12, 2019
#MyPaperBagChallenge

Matrumangal Jena

December 12, 2019
#MyPaperBagChallenge

Swarit Praharaj

December 12, 2019
#MyPaperBagChallenge

Sarmistha Nayak

December 12, 2019
#MyPaperBagChallenge

Lopali Pattnaik

December 12, 2019

Archives

Editorial

Laws For Vindictiveness

OPiate
August 25, 2025

Three new Bills were introduced in the Lok Sabha by Union Home Minister Amit Shah shortly before Parliament adjourned last...

Read moreDetails

India’s Pak Policy

AAKAR PATEL
August 24, 2025

Problems between two parties can be resolved in one of only three ways. The first is through negotiation between these...

Read moreDetails

CIC on Life Support

Silent Shift
August 23, 2025

As of September 14, the Central Information Commission (CIC) may be headless. Chief Information Commissioner Heeralal Samariya retires, and unless...

Read moreDetails

‘TACO’ Effect

August 20, 2025

It is interesting to note US President Donald Trump keeps changing his deadline for imposing new tariffs on goods from...

Read moreDetails
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2024 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2024 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2024 All rights Reserved by OrissaPOST